Ashford Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Ashford Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,900	Closed	-$409K	–	108
2016 Q3	$409K	Sell	8,900 -100	-1%	-$5.22K	0.08%	86
2016 Q2	$452K	Sell	9,000 -1,200	-12%	-$63.9K	0.1%	85
2016 Q1	$546K	Sell	10,200 -1,000	-9%	-$58.7K	0.13%	77
2015 Q4	$735K	Hold	11,200	–	–	0.17%	70
2015 Q3	$632K	Sell	11,200 -1,000	-8%	-$64.8K	0.15%	79
2015 Q2	$721K	Hold	12,200	–	–	0.16%	78
2015 Q1	$760K	Hold	12,200	–	–	0.16%	90
2014 Q4	$702K	Hold	12,200	–	–	0.14%	97
2014 Q3	$656K	Hold	12,200	–	–	0.14%	96
2014 Q2	$640K	Hold	12,200	–	–	0.13%	101
2014 Q1	$645K	Buy	+12,200	New	+$564K	0.12%	100

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Ashford Capital Management's TEVA Position: Q4 2016 in Review

Ashford Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 8,900 shares — an estimated $409K sold.

Ashford Capital Management first reported a position in TEVA in Q1 2014 and held it in 11 quarters. The position peaked at $760K in Q1 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Ashford Capital Management reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Ashford Capital Management sold 8,900 Teva Pharmaceuticals shares in Q4 2016, an estimated $409K.
Ashford Capital Management first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 11 quarters.
Ashford Capital Management's Teva Pharmaceuticals position peaked at $760K in Q1 2015.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Ashford Capital Management's 13F filing for Q4 2016, filed 15 Feb 2017.